Hepatic Cell New Volume 5.13 | Apr 16 2021

    0
    17







    2021-04-16 | HCN


    Advances in immunotherapy for hepatocellular carcinoma

    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.13 – 16 April, 2021
    TOP STORY

    Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice with Dietary Challenge

    As GLP-1 receptor (GLP-1R) is unlikely expressed in hepatocytes, scientists aimed to compare such stimulation in mice and in mouse-hepatocytes; determined the involvement of GLP-1R, and clarified whether fibroblast growth factor 21 (FGF21) mediated certain functions of the GLP-1R agonist liraglutide.
    [Hepatology]

    Abstract
    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    PUBLICATIONSRanked by the impact factor of the journal

    Directed Differentiation of Human Induced Pluripotent Stem Cells to Hepatic Stellate Cells

    Researchers describe a protocol to differentiate human induced pluripotent stem cells into hepatic stellate cells.
    [Nature Protocols]

    Abstract

    Co-encapsulation of Collagenase Type I and Silibinin in Chondroitin Sulfate Coated Multilayered Nanoparticles for Targeted Treatment of Liver Fibrosis

    Investigators demonstrated that chondroitin sulfate coated multilayered 50-nm nanoparticles encapsulating collagenase and silibinin broke down the dense collagen stroma, while silibinin inhibited activated hepatic stellate cells.
    [Carbohydrate Polymers]

    Abstract

    Bmal1 Inhibits Phenotypic Transformation of Hepatic Stellate Cells in Liver Fibrosis via IDH1/α-KG-Mediated Glycolysis

    Researchers showed that glycolysis was significantly enhanced, while the expression of brain and muscle arnt-like protein-1 (Bmal1) was downregulated in fibrotic liver tissues of mice, primary hepatic stellate cells (HSCs), and transforming growth factor-β1 (TGF-β1)-induced LX2 cells.
    [Acta Pharmaceutica Sinica B]

    Abstract

    BMP9-ID1 Signaling Promotes EpCAM-Positive Cancer Stem Cell Properties in Hepatocellular Carcinoma

    Scientists aimed to elucidate the role of Bone morphologic protein 9 (BMP9) signaling in hepatocellular carcinoma-cancer stem cells (HCC‐CSC) properties and to assess the therapeutic effect of BMP receptor inhibitors in HCC.
    [Molecular Oncology]

    Abstract

    Sirt1 Deacetylates and Stabilizes p62 to Promote Hepato-Carcinogenesis

    Investigators confirmed that p62 was up-regulated in hepatocellular carcinoma and its higher expression was associated with shorter overall survival in patients.
    [Cell Death & Disease]

    Full Article

    Assessment of Long-Term Functional Maintenance of Primary Human Hepatocytes to Predict Drug-Induced Hepatoxicity In Vitro

    Scientists developed a conditioned culture system composed of a small-molecule combination that could maintain hepatocyte morphology and functions over the long term.
    [Archives of Toxicology]

    Abstract

    KLF7/VPS35 Axis Contributes to Hepatocellular Carcinoma Progression through CCDC85C-Activated β-Catenin Pathway

    Researchers investigated the role of Krüppel-like factors (KLF7) in proliferation and migration of hepatocellular carcinoma (HCC) cells.
    [Cell and Bioscience]

    Full Article

    Metformin Regulates the Th17/Treg Balance by Glycolysis with TIGAR in Hepatic Ischemia-Reperfusion Injury

    The ischemia-reperfusion (I/R) liver injury rat model and the primary hepatocyte hypoxia/reoxygenation injury model were established. The biochemical indexes, inflammatory factor indexes, Th17/Treg balance and energy metabolism were evaluated.
    [Journal of Pharmacological Sciences]

    Full Article
    Learn more about HepatiCult Organoid Growth Medium (Mouse)
    REVIEWS

    Advances in Immunotherapy for Hepatocellular Carcinoma

    The authors provide up-to-date information on the best use of currently available immunotherapies in hepatocellular carcinoma and the therapeutic strategies under development.
    [Nature Reviews Gastroenterology & Hepatology]

    Full Article

    Inflammatory Processes in the Liver: Divergent Roles in Homeostasis and Pathology

    Scientists review the dynamic roles of inflammatory mediators in responses to sterile injury in the context of homeostasis and disease, the clinical implications of dysregulated hepatic immune activity and therapeutic developments to regulate liver-specific immunity.
    [Cellular & Molecular Immunology]

    Abstract

    Critical Signaling Pathways Governing Hepatocellular Carcinoma Behavior; Small Molecule-Based Approaches

    The authors provide the latest findings on critical signaling pathways governing hepatocellular carcinoma (HCC) behavior and using small molecules in the control of HCC both in vitro and in vivo models.
    [Cancer Cell International]

    Full Article
    INDUSTRY AND POLICY NEWS

    VBI Vaccines Announces Phase Ib/IIa Data and Progress of Hepatitis B Immunotherapeutic Candidate

    VBI Vaccines, Inc. announced data and next steps from the high-dose cohort of its Phase Ib/IIa clinical study of VBI-2601, the company’s hepatitis B immunotherapeutic candidate, in chronically-infected hepatitis B patients.
    [VBI Vaccines, Inc. (businesswire)]

    Press Release

    Axcella Announces AXA1125’s IND Clearance for the Treatment of NASH

    Axcella, announced that it had achieved a key milestone with U.S. FDA clearance of an Investigational New Drug (IND) application for AXA1125, enabling the company to proceed directly into a Phase IIb clinical trial.
    [Axcella (businesswire)]

    Press Release

    FEATURED EVENT

    23rd Biennial Meeting of the International Society for Developmental Neuroscience

    May 25 – 27, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Associate Director – Liver Pharmacology

    Translate Bio – Lexington, Massachusetts, United States

    Research Assistant – Liver Immunology

    Institute of Hepatology – London, United Kingdom

    Postdoctoral Fellow – Pancreatic Liver Metastasis

    Karolinska Institutet – Huddinge, Sweden

    Research Scientist- Liver

    Spark Therapeutics – Philadelphia, Pennsylvania, United States

    Postdoctoral Scientist – Senescence and Cancer

    Cancer Research Center of Lyon – Lyon, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter